Sitostenone

CAS No. 1058-61-3

Sitostenone ( —— )

Catalog No. M22863 CAS No. 1058-61-3

Sitostenone has antioxidation activity. Stigmasta-4-en-3-one(Sitostenone) can be used for the treatment of androgen-dependent diseases, especially for the treatment of benign prostatic hyperplasia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 216 In Stock
10MG 320 In Stock
25MG 529 In Stock
50MG 770 In Stock
100MG 1062 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sitostenone
  • Note
    Research use only, not for human use.
  • Brief Description
    Sitostenone has antioxidation activity. Stigmasta-4-en-3-one(Sitostenone) can be used for the treatment of androgen-dependent diseases, especially for the treatment of benign prostatic hyperplasia.
  • Description
    Sitostenone has antioxidation activity. Stigmasta-4-en-3-one(Sitostenone) can be used for the treatment of androgen-dependent diseases, especially for the treatment of benign prostatic hyperplasia.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1058-61-3
  • Formula Weight
    412.7
  • Molecular Formula
    C29H48O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCC(CCC(C)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Antioxidant and anticancer aporphine alkaloids from the leaves of Nelumbo nucifera Gaertn. cv. Rosa-plena. Molecules. 2014 Nov 3;19(11):17829-38
molnova catalog
related products
  • Ginkgolic acid

    Ginkgolic acid C13: exhibits the highest α-glucosidase inhibitory activity.

  • VPC-80051 racemate

    VPC-80051 is the first small molecule inhibitor of hnRNP A1 splicing activity by using a computer-aided drug discovery approach.

  • 36-Dihydroxyflavone

    36-Dihydroxyflavone?suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway.